<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization - Zee, AAG - 2017 | Cochrane Library</title> <meta content="Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization - Zee, AAG - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006681.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization - Zee, AAG - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006681.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006681.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization" name="citation_title"/> <meta content="Aniek AG Zee" name="citation_author"/> <meta content="VieCuri Medical Centre of Northern Limburg" name="citation_author_institution"/> <meta content="aniek_zee@hotmail.com" name="citation_author_email"/> <meta content="Kelly van Lieshout" name="citation_author"/> <meta content="Deventer Ziekenhuis" name="citation_author_institution"/> <meta content="Maaike van der Heide" name="citation_author"/> <meta content="VieCuri Medical Centre of Northern Limburg" name="citation_author_institution"/> <meta content="Loes Janssen" name="citation_author"/> <meta content="VieCuri Medical Centre of Northern Limburg" name="citation_author_institution"/> <meta content="Heinrich MJ Janzing" name="citation_author"/> <meta content="VieCuri Medical Centre of Northern Limburg" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD006681.pub4" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/08/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006681.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006681.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006681.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [adverse effects, *therapeutic use]; Cause of Death; Hemorrhage [chemically induced]; Heparin, Low‐Molecular‐Weight [adverse effects, *therapeutic use]; Immobilization [*adverse effects]; Leg Injuries [*therapy]; Pulmonary Embolism [epidemiology, prevention &amp; control]; Randomized Controlled Trials as Topic; Venous Thromboembolism [*prevention &amp; control]; Venous Thrombosis [epidemiology, prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006681.pub4&amp;doi=10.1002/14651858.CD006681.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="6iOnQIUh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006681\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006681\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006681.pub4",title:"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower\\u2010limb immobilization",firstPublishedDate:"Aug 6, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6iOnQIUh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006681.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006681.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006681.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006681.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006681.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006681.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006681.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006681.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006681.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006681.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7472 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006681.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-sec-0077"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-sec-0071"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/appendices#CD006681-sec-0082"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/table_n/CD006681StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/table_n/CD006681StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#CD006681-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Aniek AG Zee</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#CD006681-cr-0003">Kelly van Lieshout</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#CD006681-cr-0004">Maaike van der Heide</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#CD006681-cr-0005">Loes Janssen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information#CD006681-cr-0006">Heinrich MJ Janzing</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information/en#CD006681-sec-0091">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 August 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006681.pub4">https://doi.org/10.1002/14651858.CD006681.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006681-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006681-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006681-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006681-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006681-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006681-abs-0001" lang="en"> <section id="CD006681-sec-0001"> <h3 class="title" id="CD006681-sec-0001">Background</h3> <p>Immobilization of the lower limb is a risk factor for venous thromboembolism (VTE). Low molecular weight heparins (LMWHs) are anticoagulants, which might be used in adult patients with lower‐limb immobilization to prevent deep venous thrombosis (DVT) and its complications. This is an update of the review first published in 2008. </p> </section> <section id="CD006681-sec-0002"> <h3 class="title" id="CD006681-sec-0002">Objectives</h3> <p>To assess the effectiveness of low molecular weight heparin for the prevention of venous thromboembolism in patients with lower‐limb immobilization in an ambulatory setting. </p> </section> <section id="CD006681-sec-0003"> <h3 class="title" id="CD006681-sec-0003">Search methods</h3> <p>For this update, the Cochrane Vascular Information Specialist searched the Specialised Register, CENTRAL, and three trials registers (April 2017). </p> </section> <section id="CD006681-sec-0004"> <h3 class="title" id="CD006681-sec-0004">Selection criteria</h3> <p>Randomized controlled trials (RCTs) and controlled clinical trials (CCTs) that described thromboprophylaxis by means of LMWH compared with no prophylaxis or placebo in adult patients with lower‐limb immobilization. Immobilization was by means of a plaster cast or brace. </p> </section> <section id="CD006681-sec-0005"> <h3 class="title" id="CD006681-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials, assessed risk of bias and extracted data. The review authors contacted the trial authors for additional information if required. Statistical analysis was carried out using Review Manager 5. </p> </section> <section id="CD006681-sec-0006"> <h3 class="title" id="CD006681-sec-0006">Main results</h3> <p>We included eight RCTs that fulfilled our criteria, with a total of 3680 participants. The quality of evidence, according GRADE, varied by outcome and ranged from low to moderate. We found an incidence of DVT ranging from 4.3% to 40% in patients who had a leg injury that had been immobilized in a plaster cast or a brace for at least one week, and who received no prophylaxis, or placebo. This number was significantly lower in patients who received daily subcutaneous injections of LMWH during immobilization, with event rates ranging from 0% to 37% (odds ratio (OR) 0.45, 95% confidence interval (CI) 0.33 to 0.61; with minimal evidence of heterogeneity: I² = 26%, P = 0.23; seven studies; 1676 participants, moderate‐quality evidence). Comparable results were seen in the following groups of participants: patients with below‐knee casts, conservatively treated patients (non‐operated patients), operated patients, patients with fractures, patients with soft‐tissue injuries, and patients with distal or proximal thrombosis. No clear differences were found between the LMWH and control groups for pulmonary embolism (OR 0.50, 95% CI 0.17 to 1.47; with no evidence of heterogeneity: I² = 0%, P = 0.56; five studies, 2517 participants; low‐quality evidence). The studies also showed less symptomatic VTE in the LMWH groups compared with the control groups (OR 0.40, 95% CI 0.21 to 0.76; with minimal evidence of heterogeneity: I² = 16%, P = 0.31; six studies; 2924 participants; low‐quality evidence). One death was reported in the included studies, but no deaths due to pulmonary embolism were reported. Complications of major adverse events were rare, with minor bleeding the main adverse events reported. </p> </section> <section id="CD006681-sec-0007"> <h3 class="title" id="CD006681-sec-0007">Authors' conclusions</h3> <p>Moderate‐quality evidence showed that the use of LMWH in outpatients reduced DVT when immobilization of the lower limb was required, when compared with no prophylaxis or placebo. The quality of the evidence was reduced to moderate because of risk of selection and attrition bias in the included studies. Low‐quality evidence showed no clear differences in PE between the LMWH and control groups, but less symptomatic VTE in the LMWH groups. The quality of the evidence was downgraded due to risk of bias and imprecision. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006681-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006681-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006681-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006681-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006681-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006681-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006681-abs-0003" lang="en"> <h3>Low molecular weight heparin for prevention of venous thromboembolism in adults with lower‐limb immobilization in an outpatient setting </h3> <p><b>Background</b> </p> <p>Venous thromboembolism is a condition where a blood clot forms in the deep veins (DVT), most commonly of the leg. The concern is that it can travel up to block the arteries in the lungs (pulmonary embolism). In adult patients, immobilization of the lower limb with a plaster cast or brace is a risk factor for DVT and pulmonary embolism. To prevent this complication, preventive treatment with anticoagulants (medication that thins the blood) is often used, most commonly, low molecular weight heparin (LMWH). However, there is no agreement on this in existing national guidelines. Therefore, we searched the literature for trials on this topic, in order to assess the evidence. </p> <p><b>Study characteristics and key results</b> </p> <p>We included eight studies in this review (current until April 2017). The studies included a total of 3680 participants. Participants received either LMWH subcutaneously once daily, or no preventive treatment or placebo. New cases of DVT ranged from 4.3% to 40% in the control groups and ranged from 0% to 37% in the LMWH groups. The risk of DVT was lower in participants who received LMWH. Further analysis also showed a reduction in the occurrence of DVT when the use of LMWH was compared to no treatment or placebo in the following groups of participants: patients with below‐knee casts, conservatively treated patients (patients not operated), operated patients, patients with fractures, patients with soft‐tissue injuries, patients with above‐knee thrombosis, and patients with below‐knee thrombosis. No clear differences were found between the LMWH and control groups for pulmonary embolism. The studies showed less symptomatic venous thromboembolism in the LMWH groups compared with the control groups. No cases of death due to pulmonary embolism were reported. One study reported one death in the control group. </p> <p>There were few reported adverse effects in the treated patients. The main adverse events reported were cases of minor bleeding such as nose bleeds, blood in urine and dark stool. </p> <p><b>Quality of evidence and conclusion</b> </p> <p>The use of LMWH in adult patients reduced DVT when immobilization of the lower limb was required, compared with no prevention or placebo. The quality of the evidence was downgraded to moderate due to risks of bias in some trials, such as lack of blinding of participants, or unclear reasons for excluding participants from the analyses. Low‐quality evidence showed no clear differences in pulmonary embolism between LMWH and the control groups, but fewer symptomatic venous thromboemboli in the LMWH groups. The quality of evidence was downgraded due to methodological issues and imprecision of the results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006681-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006681-sec-0077"></div> <h3 class="title" id="CD006681-sec-0078">Implications for practice</h3> <section id="CD006681-sec-0078"> <p>Moderate‐quality evidence showed that the use of low molecular weight heparin (LMWH) in outpatients reduced the number of venous thromboembolic events when a plaster cast or brace was required, when compared with no prophylaxis or placebo.The quality of evidence was downgraded to 'moderate' due to risk of selection and attrition bias. Low‐quality evidence showed no clear differences in PE between the LMWH and control groups, but less symptomatic VTE in the LMWH group. The quality of evidence was downgraded due to risk of bias and imprecision of results. </p> </section> <h3 class="title" id="CD006681-sec-0079">Implications for research</h3> <section id="CD006681-sec-0079"> <p>Even with LMWH as a prophylactic measure, incidence rates of DVT, ranging from 0% to 10%, indicate a high absolute rate of morbidity in the population. In order to reduce the number of venous thromboembolic events, we encourage research to develop less immobilizing treatment options, and investigate further the use of other drugs such as the new oral anticoagulants (NOACs). </p> <p>This review did not focus on the ongoing discussion of the clinical relevance of calf vein thrombosis. It simply confirmed its more frequent occurrence in immobilized patients. Future research might bring more clarity to the discussion on the significance of calf vein thrombosis. </p> <p>Follow‐up studies on long‐term effects of DVT after immobilization, and the incidence of post‐thrombotic syndrome in these patients, could yield valuable information on the clinical relevance of primary asymptomatic DVT. </p> <p>Low molecular weight heparin treatment in all included studies was administered once daily until removal of the plaster cast. Nevertheless, the optimal period of treatment is unclear, and further research should be conducted to gain insight into this matter. </p> <p>We did not focus on scoring systems and individual risk factors in this analysis. Future research might give more directives on specific advice for different patients or patient groups, based on patient and trauma characteristics. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006681-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006681-sec-0015"></div> <div class="table" id="CD006681-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Low molecular weight heparin compared to no prophylaxis or placebo in prevention of venous thromboembolism in patients with lower‐limb immobilization</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="7" rowspan="1" valign="top"> <p><b> Low molecular weight heparin compared to no prophylaxis or placebo in prevention of venous thromboembolism in patients with lower‐limb immobilization</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> prevention of venous thromboembolism in patients with lower‐limb immobilization<br/> <b>Setting:</b> ambulatory setting<br/> <b>Intervention:</b> low molecular weight heparin<br/> <b>Comparison:</b> no prophylaxis or placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no prophylaxis or placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with low molecular weight heparin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Deep venous thrombosis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.45<br/> (0.33 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1676<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/> (65 to 114) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pulmonary embolism</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.50<br/> (0.17 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2517<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 10) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Symptomatic venous thromboembolism</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.40<br/> (0.21 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2924<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (5 to 16) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to pulmonary embolism</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3111<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No mortality due to pulmonary embolism was reported</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to other causes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.33</p> <p>(0.01 to 8.15)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3111<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One death (in no prophylaxis/placebo group) was reported in the included studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> <p>(0 to 5)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.01<br/> (0.83 to 4.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3178<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/> (34 to 170) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*We calculated the assumed risk of the no prophylaxis or placebo group from the average risk in the no prophylaxis or placebo groups (i.e. the number of participants with events divided by total number of participants of the no prophylaxis or placebo group included in the meta‐analysis). The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level as 3 out of 7 studies showed considerable risk of bias<br/> <sup>2</sup> Downgraded by two levels as 2 out of 5 studies showed considerable risk of bias, and imprecision of pooled results<br/> <sup>3</sup> Downgraded by two levels as 3 out of 6 studies showed considerable risk of bias, and imprecision of pooled results<br/> <sup>4</sup> Downgraded by two levels due to the low number of events, and imprecision of pooled results<br/> <sup>5</sup> Downgraded by two levels as 4 out of 8 studies showed considerable risk of bias, and imprecision of pooled results </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006681-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006681-sec-0016"></div> <section id="CD006681-sec-0017"> <h3 class="title" id="CD006681-sec-0017">Description of the condition</h3> <p>Lower‐limb immobilization is associated with deep venous thrombosis (DVT) and pulmonary embolism (PE). Predisposing risk factors for venous thromboembolism (VTE) can be divided into individual patient factors, trauma, or surgery‐related factors. Patient‐related factors include: obesity, thrombophilia (a hereditary or acquired predisposition to thrombosis), a previous thrombosis, age over 40 years, or cardiac or respiratory failure (<a href="./references#CD006681-bbs2-0056" title="AndersonFA , SpencerF A . Risk factors for venous thromboembolism. Circulation2003;107(23 suppl 1):I‐9. ">Anderson 2003</a>; <a href="./references#CD006681-bbs2-0063" title="ClagettGP , AndersonFAJr , HeitJ , LevineMN , WheelerHB . Prevention of venous thromboembolism. Chest1995;108(4 Suppl):312S–34S. ">Clagett 1995</a>; <a href="./references#CD006681-bbs2-0055" title="ZagrodnickJ , KaufnerHK . Ambulatory thromboembolism prevention in traumatology using self‐injection of heparin. Unfallchirurg1990;93(7):331‐3. [Article in German] ">Zagrodnick 1990</a>). Immobilization is considered a significant risk factor for the development of DVT and PE (<a href="./references#CD006681-bbs2-0035" title="KnudsonMM , MorabitoD , PaiementGD , ShacklefordS . Use of low molecular weight heparin in preventing thromboembolism in trauma patients. Journal of Trauma: Injury Infection and Critical Care1996;41(3):446‐59. ">Knudson 1996</a>; <a href="./references#CD006681-bbs2-0037" title="KudskKA , FabianTC , BaumS , GoldRE , MangianteE , VoellerG . Silent deep vein thrombosis in immobilized multiple trauma patients. American Journal of Surgery1989;158(6):515‐9. ">Kudsk 1989</a>; <a href="./references#CD006681-bbs2-0074" title="KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1991;23(suppl 1):20–6. ">Kujath 1991</a>). Other factors associated with an increased risk of VTE include: blood transfusion, surgery, fracture of the pelvis, femur, or tibia, spinal cord injury, head injury, shock on hospital admission, venous injury, more than three days on ventilation, the time from injury to operation, and operation time (<a href="./references#CD006681-bbs2-0009" title="AbelsethG , BuckleyRE , PineoGE , HullR , RoseMS . Incidence of deep‐vein thrombosis in patients with fractures of the lower extremity distal to the hip. Journal of Orthopaedic Trauma1996;10(4):230‐5. ">Abelseth 1996</a>; <a href="./references#CD006681-bbs2-0036" title="KnudsonMM , IkossiDG , KhawL , MorabitoD , SpeetzenL . Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Annals of Surgery2004;240(3):490–6, discussion 496‐8. ">Knudson 2004</a>). </p> <p>In a group of 102 patients with lower‐limb fractures, Abelseth found a rate of DVT of 28% (<a href="./references#CD006681-bbs2-0009" title="AbelsethG , BuckleyRE , PineoGE , HullR , RoseMS . Incidence of deep‐vein thrombosis in patients with fractures of the lower extremity distal to the hip. Journal of Orthopaedic Trauma1996;10(4):230‐5. ">Abelseth 1996</a>). All patients underwent surgery and were mobilized without the use of a plaster cast. Proximal fractures were associated with a higher risk of DVT compared with more distal fractures (<a href="./references#CD006681-bbs2-0009" title="AbelsethG , BuckleyRE , PineoGE , HullR , RoseMS . Incidence of deep‐vein thrombosis in patients with fractures of the lower extremity distal to the hip. Journal of Orthopaedic Trauma1996;10(4):230‐5. ">Abelseth 1996</a>). Other reported incidences of venographically‐proven DVT in patients with lower‐limb fractures range from 27% to 78% (<a href="./references#CD006681-bbs2-0016" title="BreyerH , KoppenhagenK , MabikiM , RahmanzadehR . The risk of thromboembolism due to plaster cast immobilisation and operation of the lower extremity [Thromboserisko durch Gipsimmobilisation und Operation an der unteren Extremitaet]. Hefte zur Unfallheilkunde1984;164:423‐4. ">Breyer 1984</a>; <a href="./references#CD006681-bbs2-0023" title="GeertsWH , CodeKI , JayRM , ChenE , SzalaiJP . A prospective study of venous thromboembolism after major trauma. New England Journal of Medicine1994;331(24):1601‐6. ">Geerts 1994</a>; <a href="./references#CD006681-bbs2-0032" title="HjelmstedtA , BergvallU . Incidence of thrombosis in patients with tibial fractures. Acta Chirurgica Scandinavica1968;134(3):209‐18. ">Hjelmstedt 1968</a>; <a href="./references#CD006681-bbs2-0037" title="KudskKA , FabianTC , BaumS , GoldRE , MangianteE , VoellerG . Silent deep vein thrombosis in immobilized multiple trauma patients. American Journal of Surgery1989;158(6):515‐9. ">Kudsk 1989</a>; <a href="./references#CD006681-bbs2-0052" title="SpielerU , PreterB , BrunnerU . Traumatic thromboses of the deep venous system in recent tibial fractures [Traumatische thrombosen im tiefen venensystem bei frischen unterschenkelfrakturen]. Schweizerische Medizinische Wochenschrift1972;102(43):1535‐40. ">Spieler 1972</a>). The percentages in hospitalized patients are generally higher than in outpatients. In outpatients immobilized in plaster casts without LMWH, the incidence of DVT on ultrasonography ranges from 4.5% to 16.5% (<a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0047" title="ReilmannH , WeinbergAM , ForsterEE , HappeB . Prevention of thrombosis in ambulatory patients. Orthopade1993;22(2):117‐20. [Article in German] ">Reilmann 1993</a>; <a href="./references#CD006681-bbs2-0055" title="ZagrodnickJ , KaufnerHK . Ambulatory thromboembolism prevention in traumatology using self‐injection of heparin. Unfallchirurg1990;93(7):331‐3. [Article in German] ">Zagrodnick 1990</a>). The incidence of PE in trauma patients with DVT without prophylaxis is 4.3%, with a high mortality rate (20% to 23.3%). In patients with DVT receiving thromboprophylaxis, this incidence can be lowered to 0.3% to 2.0% (<a href="./references#CD006681-bbs2-0071" title="HillAB , GarberB , DervinG , HowardA . Heparin prophylaxis for deep venous thrombosis in a patient with multiple injuries: an evidence‐based approach to a clinical problem. Canadian Journal of Surgery2002;45(4):282–7. ">Hill 2002</a>). </p> </section> <section id="CD006681-sec-0018"> <h3 class="title" id="CD006681-sec-0018">Description of the intervention</h3> <p>The primary goal of administering thromboprophylaxis is to prevent PE and DVT and their sequelae. Oral anticoagulants, unfractionated heparin (UFH) and LMWH, have been studied as treatment options for this indication. In clinical guidelines, the recommendations for preventing venous thrombosis in patients with isolated lower‐limb injuries distal to the knee are sparse. The Italian Intersociety Consensus Statement states that most patients in orthopedic and traumatological fields, other than knee and hip replacements, should be considered for thromboprophylaxis after individual assessment of haemorrhagic risk (<a href="./references#CD006681-bbs2-0065" title="Della RoccaG , DanelliG , RandelliF , RomaniniE , BiggiF , LauroraNR , et al. II Italian intersociety consensus statement on antithrombotic prophylaxis in orthopedics and traumatology. Minerva Anestesiologica2013;79(7):778‐92. ">Della Rocca 2013</a>). Guidelines in Emergency Medicine Network in the United Kingdom (GEMNet) only advises the use of thromboprophylaxis in patients with rigid cast immobilization and a permanent risk factor for VTE (<a href="./references#CD006681-bbs2-0079" title="RobertsC , HornerD , ColemanG , MaitlandL , Curl‐RoperTh , SmithR , WoodE , Mackway‐JonesK . Guidelines in Emergency Medicine Network (GEMNet): guideline for the use of thromboprophylaxis in ambulatory trauma patients requiring temporary limb immobilisation. Emergency Medicine Journal2013;30(11):968‐82. ">Roberts 2013</a>). </p> <p>There remains substantial practice variation amongst surgeons regarding the use of anticoagulation measures (<a href="./references#CD006681-bbs2-0059" title="BatraS , KurupH , GulA , AndrewJG . Thromboprophylaxis following cast immobilisation for lower limb injuries‐survey of current practice in United Kingdom. Injury2006;37(9):813–7. ">Batra 2006</a>). In daily clinical practice, there remains a huge variation in the way thromboprophylaxis is used. A recent survey among Dutch orthopedic and trauma surgeons showed that 60% to 80% always prescribed thromboprophylaxis in patients with lower‐limb immobilization. Up to 8% of the participants never treated their patients with prophylaxis (<a href="./references#CD006681-bbs2-0083" title="vanAdrichemRA , vanOostenJP , CannegieterSC , SchipperIB , NelissenRGHH . Thromboprophylaxis for lower leg cast immobilisation and knee arthroscopy: a survey study. Netherlands Journal of Medicine2015;73(1):23‐9. ">van Adrichem 2015</a>). </p> </section> <section id="CD006681-sec-0019"> <h3 class="title" id="CD006681-sec-0019">How the intervention might work</h3> <p>Low molecular weight heparin is proven to be effective in the prevention of venous thromboembolism (<a href="./references#CD006681-bbs2-0084" title="WeitzJ . Low‐molecular‐weight heparins. New England Journal of MedicineSeptember 1997;Volume 337(10):688‐98. ">Weitz 1997</a>). By treating patients with lower‐limb immobilization with LMWH, we expect to see less venous thromboembolism compared to patients who do not receive any protection. </p> </section> <section id="CD006681-sec-0020"> <h3 class="title" id="CD006681-sec-0020">Why it is important to do this review</h3> <p>This is the second update of the Cochrane review first published in 2008 (first update 2014). Since 2014, two additional studies on this subject have been published (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). Therefore, in order to include the most recent information, we updated this review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006681-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006681-sec-0021"></div> <p>To assess the effectiveness of low molecular weight heparin for the prevention of venous thromboembolism in patients with lower‐limb immobilization in an ambulant setting. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006681-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006681-sec-0022"></div> <section id="CD006681-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006681-sec-0024"> <h4 class="title">Types of studies</h4> <p>We considered all randomized controlled trials (RCTs) and controlled clinical trials (CCTs) that describe thromboprophylaxis, by means of low molecular weight heparin (LMWH), in adults with lower‐limb immobilization in an ambulatory setting. Treatment with LMWH could have started during hospital admission. </p> </section> <section id="CD006681-sec-0025"> <h4 class="title">Types of participants</h4> <p>Adults treated with a device for lower‐limb immobilization, such as a leg cast or brace, in an ambulatory setting. Weight bearing and duration of leg cast use were not considered criteria for inclusion or exclusion. </p> </section> <section id="CD006681-sec-0026"> <h4 class="title">Types of interventions</h4> <p>Studies comparing LMWH with no prophylaxis or placebo. Studies including oral anticoagulants, UFH, or aspirin were excluded. </p> </section> <section id="CD006681-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD006681-sec-0028"> <h5 class="title">Primary outcomes</h5> <p>Morbidity</p> <p> <ul id="CD006681-list-0001"> <li> <p>DVT ‐ confirmed by venography or ultrasonography</p> </li> <li> <p>PE ‐ confirmed by a ventilation‐perfusion scan, a CT scan, or angiography</p> </li> <li> <p>Symptomatic VTE ‐ symptomatic DVT, PE, or combination</p> </li> </ul> </p> </section> <section id="CD006681-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD006681-list-0002"> <li> <p>Mortality ‐ PE‐related</p> </li> <li> <p>Mortality ‐ other causes</p> </li> <li> <p>Adverse outcomes of treatment: bleeding, heparin induced thrombocytopenia (HIT), allergic reaction, others (definitions of adverse outcomes as reported by study authors). </p> </li> </ul> </p> </section> </section> </section> <section id="CD006681-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <p> </p> <section id="CD006681-sec-0031"> <h4 class="title">Electronic searches</h4> <p>For this update, the Cochrane Vascular Information Specialist (CIS) searched the following databases for relevant trials. </p> <p> <ul id="CD006681-list-0003"> <li> <p>The Cochrane Vascular Specialised Register (19 April 2017).</p> </li> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 3) via the Cochrane Register of Studies Online (searched 19 April 2017). </p> </li> </ul> </p> <p>See <a href="./appendices#CD006681-sec-0083">Appendix 1</a> for details of the search strategy used for CENTRAL. </p> <p>The Cochrane Vascular Specialised Register is maintained by the CIS and is constructed from weekly electronic searches of MEDLINE Ovid, Embase Ovid, CINAHL, and AMED, as well as through handsearching relevant journals. The full list of the databases, journals, and conference proceedings searched, as well as the search strategies used, are described in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Vascular module in the <a href="http://www.cochranelibrary.com" target="_blank">Cochrane Library</a>. </p> <p>In addition, the CIS searched the following trials registers for details of ongoing and unpublished studies (19 April 2017). See <a href="https://archie.cochrane.org/sections/documents/view?version=z1706201421203095205485308444738%26format=REVMAN#APP-02" target="_blank">Appendix 2</a> </p> <p> <ul id="CD006681-list-0004"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>) </p> </li> <li> <p>International Standard Randomised Controlled Trial Number (ISRCTN) registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com</a>). </p> </li> </ul> </p> </section> <section id="CD006681-sec-0032"> <h4 class="title">Searching other resources</h4> <p>The review authors searched the reference lists of relevant studies.</p> </section> </section> <section id="CD006681-sec-0033"> <h3 class="title" id="CD006681-sec-0033">Data collection and analysis</h3> <section id="CD006681-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Two review authors (KL and MH) independently assessed all studies identified by the literature searches, according to the inclusion criteria. Disagreements were resolved by discussion. </p> </section> <section id="CD006681-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (MH and AZ) independently extracted data to ensure objectivity and validity of findings. A third review author (HJ) cross checked the information, and disagreements were resolved by discussion. The review authors contacted trial authors for additional information if required. </p> </section> <section id="CD006681-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (KL and AZ) independently assessed the risk of bias of the included studies by using Cochrane's 'Risk of bias' tool (<a href="./references#CD006681-bbs2-0070" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). Random sequence generation, allocation concealment, blinding of participants, personnel, and outcome assessors, incomplete outcome data, selective outcome reporting, and any other relevant biases were classified as 'low risk', 'high risk' or 'unclear risk'. They resolved any disagreement through discussion with review authors HJ and LJ. </p> </section> <section id="CD006681-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>We measured treatment effect by calculating odds ratios (OR) with 95% confidence interval (CI) for dichotomous data. </p> </section> <section id="CD006681-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>The individual participant was considered the unit of analysis.</p> </section> <section id="CD006681-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>Where appropriate, we used all randomized participants for the analysis. However, many of the included studies had participants excluded after randomization, creating a disparity between the number of participants randomized and the number available for assessment of VTE outcomes. Therefore, we used the data from the populations as reported by the studies. These generally consisted of all participants who received treatment and had evaluable testing of VTE at the end of the study. If these values were not available, we used the reported per‐protocol data. </p> </section> <section id="CD006681-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>Statistical analysis was carried out using Review Manager 5 (<a href="./references#CD006681-bbs2-0078" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Review author LJ coordinated the statistical analysis. We searched for clinical and statistical heterogeneity by visually inspecting the forest plots. We quantified statistical heterogeneity by means of an I² test (<a href="./references#CD006681-bbs2-0064" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Deeks 2011</a>; <a href="./references#CD006681-bbs2-0070" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). We interpreted an I² value higher than 50% as an indicator for substantial heterogeneity. </p> </section> <section id="CD006681-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>We had planned to perform funnel plot analyses to assess reporting bias, when ten or more studies were included. </p> </section> <section id="CD006681-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We synthesized available data using Review Manager 5 (<a href="./references#CD006681-bbs2-0078" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We investigated pooled estimates of the effects of treatment using a fixed‐effect model to calculate ORs with 95% CIs for dichotomous outcomes. When substantial heterogeneity was detected, we performed a random‐effects model analysis instead. If it was not possible to pool data, we planned to describe the results reported by the studies in the text. </p> </section> <section id="CD006681-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We presented data by different groups of participants. These groups were selected, as these particular patient categories may influence the outcome. </p> <p> <ul id="CD006681-list-0005"> <li> <p>DVT: regardless of type of plaster, whether operated or not</p> </li> <li> <p>DVT: in below‐knee cast, whether operated or not</p> </li> <li> <p>DVT: only non‐operated patients</p> </li> <li> <p>DVT: only operated patients</p> </li> <li> <p>DVT: fractures</p> </li> <li> <p>DVT: soft‐tissue injuries</p> </li> <li> <p>DVT: distal segment</p> </li> <li> <p>DVT: proximal segment</p> </li> </ul> </p> </section> <section id="CD006681-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>If any trials were judged to be of high risk of bias, we planned to perform a sensitivity analysis to assess outcomes with and without trials with high risk of bias. </p> <section id="CD006681-sec-0045"> <h5 class="title">Summary of findings</h5> <p>We constructed a 'Summary of findings' table for the comparison LMWH compared to no prophylaxis or placebo in prevention of venous thromboembolism with lower‐limb immobilization' using the GRADEpro GDT software to present the main findings of the review (<a href="./references#CD006681-bbs2-0068" title="McMaster University (developed by Evidence Prime, Inc). GRADEpro Guideline Development Tool (GRADEpro GDT). Version 2015. McMaster University (developed by Evidence Prime, Inc), Available from www.gradepro.org. ">GRADEpro GDT 2015</a>). We judged the outcomes deep venous thrombosis, pulmonary embolism, symptomatic venous thromboembolism, mortality due to pulmonary embolism, mortality due to other causes, and adverse outcomes, to be the most clinically relevant to healthcare professionals and patients. We calculated assumed control intervention risks from the mean number of events in the control groups of the selected studies for each outcome. We used the system developed by the GRADE Working Group to grade the quality of the evidence as high, moderate, low, or very low, based on within‐study risk of bias, directness of evidence, heterogeneity, precision of effects estimates, and risk of publication bias (<a href="./references#CD006681-bbs2-0058" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐4. ">Atkins 2004</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006681-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006681-sec-0046"></div> <section id="CD006681-sec-0047"> <h3 class="title">Description of studies</h3> <section id="CD006681-sec-0048"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD006681-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD006681-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram" data-id="CD006681-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram</p> </div> </div> </div> </section> <section id="CD006681-sec-0049"> <h4 class="title">Included studies</h4> <p>We included eight RCTs (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). The characteristics of these eight studies are summarized in the <a href="./references#CD006681-sec-0097" title="">Characteristics of included studies</a> table. All eight studies were reported as full papers and included a total of 3680 participants (range 105 to 1519). The participants included in the trials required lower‐limb immobilization for the treatment of leg injuries such as foot and ankle fractures and achilles ruptures. All studies included participants prospectively, with quite similar exclusion criteria. The most common exclusion criteria were: pregnancy, allergy to heparin or contrast media, uncontrolled hypertension, pre‐existing bleeding disorders, presence of malignancies, recent brain or gastrointestinal bleeding, previous DVT, and chronic venous insufficiency. Different LMWHs were used; they were administered once daily until removal of the plaster cast: nadroparin (2850 anti‐XA IU) (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>), nadroparin (36 mg) (<a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>), certoparin (Mono‐Embolex NM; 32 mg) (<a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>), tinzaparin (3500 anti‐Xa IU) (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>), dalteparin (5000 IU) (<a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>), dalteparin (2500 IU or 5000 IU depending on body weight) <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>), and reviparin (1750 anti‐XA IU) (<a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). There were no relevant differences between treatment and control groups regarding demographics or risk factors. </p> <p>In two studies, plaster cast fitted following surgery was used as an exclusion criterion (<a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>). In one study, patients who underwent surgery before randomization might have had heparin treatment for up to four days before randomization (<a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). Another study treated all patients for one week with LMWH before randomization (<a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). The included studies differed in the types of plaster cast (upper‐leg, lower‐leg, cylinder, or brace). There was also a variation in the duration of immobilization, ranging from 15 days (<a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>), to 43 days (<a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>). </p> <p>In the included studies, the primary outcome parameter was DVT. Deep venous thrombosis, both symptomatic and asymptomatic, was diagnosed by means of ascending venography (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>), or ultrasound (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>). In these seven studies, every participant underwent a diagnostic exam. One study only performed ultrasound in participants who reported symptoms (<a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). </p> <p>Clinically‐suspected PE had to be confirmed by ventilation‐perfusion scintigraphy, angiography, or spiral CT‐scanning. Information concerning the number of patients with symptomatic and asymptomatic DVT and the extent of the DVT was collected. Secondary outcome parameters were mortality and side effects in both treatment and control groups. </p> </section> <section id="CD006681-sec-0050"> <h4 class="title">Excluded studies</h4> <p>For this update, we excluded an additional nine studies, leading to a combined total of 47 excluded articles (<a href="./references#CD006681-bbs2-0014" title="AyhanH , IyigunE , InceS , CanMF , HatipogluS , SaglamM . Comparison of three different protocols in the prevention of postoperative deep vein thrombosis in patients at high‐risk: randomized clinical study. European Surgical Research2013;50:64‐5. [PUBMED: 23736377] ">Ayhan 2013</a>; <a href="./references#CD006681-bbs2-0018" title="CookD , MeadeM , GuyattG , WalterSD , Heels‐AnsdellD , GeertsW , et al. PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan. Journal of Critical Care2011;26(2):223.e1‐9. [PUBMED: 21482348 ] ">Cook 2011</a>; <a href="./references#CD006681-bbs2-0019" title="CvirnG , WahaJE , LedinskiG , SchlagenhaufA , LeschnikB , KoestenbergerM , et al. Bed rest does not induce hypercoagulability. European Journal of Clinical Investigation2015 Jan;45(1):63‐9. [PUBMED: 25413567 ] ">Cvirn 2015</a>; <a href="./references#CD006681-bbs2-0022" title="GarciaDA . ACP Journal Club. Dalteparin did not differ from unfractionated heparin for reducing proximal DVT in critically ill patients. New England Journal of Medicine2011;155(2):JC1‐7. [PUBMED: 21768573] ">Garcia 2011</a>; <a href="./references#CD006681-bbs2-0033" title="HornerD , HoggK , BodyR , NashMJ , BaglinT , Mackway‐JonesK . The anticoagulation of calf thrombosis (ACT) project: results from the randomized controlled external pilot trial. Chest2014 Dec;146(6):1468‐77. [PUBMED: 25010443 ] ">Horner 2014</a>; <a href="./references#CD006681-bbs2-0039" title="LimW , MeadeM , LauzierF , ZarychanskiR , MehtaS , LamontagneF , et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical‐surgical critically ill patients. Critical Care Medicine2015;43(2):401‐10. [PUBMED: 25474533 ] ">Lim 2015</a>; <a href="./references#CD006681-bbs2-0048" title="SamamaCM , LecoulesN , KierzekG , ClaessensYE , RiouB , RosencherN , et al. Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi‐rigid immobilization for isolated non‐surgical below‐knee injury. Journal of Thrombosis and Haemostasis2013;11(10):1833‐43. [PUBMED: 23965181] SamamaCM , LecoulesN , KierzekG , ClaessensYE , RiouB , RosencherN , et al. Comparison of fondaparinux with low‐molecular‐weight heparin for venous thromboembolism prevention in patients requiring rigid or semi‐rigid Immobilization for isolated non‐surgical below‐knee injury [Étude comparant le fondaparinux à une héparine de bas poidsmoléculaire dans la prévention de la maladie thromboembolique veineuseen cas d’immobilisation rigide ou semi‐rigide après traumatisme isolénon chirurgical du membre inférieur au‐dessous du genou]. Annales Francaises de Medecine d'Urgence2014;4(3):153‐66. ">Samama 2013</a>; <a href="./references#CD006681-bbs2-0049" title="SaragasNP , FerraoPN , SaragasE , JacobsonBF . The impact of risk assessment on the implementation of venous thromboembolism prophylaxis in foot and ankle surgery. Foot and Ankle Surgery2014 Jun;20(2):85‐9. [PUBMED: 24796824 ] ">Saragas 2014</a>; <a href="./references#CD006681-bbs2-0053" title="WarotM , SynowiecT , Wencel‐WarotA , DaroszewskiP , BojarI , MickerM , et al. Can deep vein thrombosis be predicted after varicose vein operation in women in rural areas?. Annals of Agricultural and Environmental Medicine2014;21(3):601‐5. [PUBMED: 25292137 ] ">Warot 2014</a>). We stated the reasons for exclusion in the <a href="./references#CD006681-sec-0098" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD006681-sec-0051"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD006681-fig-0002">Figure 2</a>; <a href="#CD006681-fig-0003">Figure 3</a> </p> <div class="figure" id="CD006681-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias domain, presented as percentages across all included studies" data-id="CD006681-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias domain, presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD006681-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias domain for each included study" data-id="CD006681-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias domain for each included study </p> </div> </div> </div> <section id="CD006681-sec-0052"> <h4 class="title">Allocation</h4> <p>We judged five studies at low risk of random sequence generation (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>), and three trials to be of unclear risk of bias, because insufficient information was provided (<a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). In two studies, participants were not recruited when study personnel were off duty (<a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). </p> <p>We judged three studies at low risk of random sequence generation (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>), and five trials to be of unclear risk of bias, because information on allocation concealment was not reported (<a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). </p> </section> <section id="CD006681-sec-0053"> <h4 class="title">Blinding</h4> <p>We judged four studies at high risk of performance bias, as they were open‐label studies, with the control group receiving no prophylaxis (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). We judged one study at low risk of performance bias, as participants and personnel were blinded to treatment assignment (<a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). We judged three studies to be of unclear risk of bias, as the blinding of study personnel was not explicitly reported (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). </p> <p>We judged two studies to be of unclear risk of detection bias, because no information on blinding of outcome assessors was provided (<a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). We judged the remainder of the included studies to be at low risk of detection bias (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). </p> </section> <section id="CD006681-sec-0054"> <h4 class="title">Incomplete outcome data</h4> <p>We judged three studies at high risk of attrition bias, because the number of participants excluded from analysis was either high (higher than 30%) or reasons were not clearly described per treatment assignment (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>). We judged the remainder of the included studies to be at low risk of attrition bias, as the number of participants excluded from analyses was either low or clearly described (<a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). </p> </section> <section id="CD006681-sec-0055"> <h4 class="title">Selective reporting</h4> <p>We judged five studies to be at low risk of reporting bias, as all planned outcome measures, including adverse events, were reported (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). We judged three studies to be of unclear risk of bias, since the methods sections of the study reports did not describe planned primary and secondary outcomes, therefore, we were unable to judge if all outcomes were reported (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>). <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a> reported on primary outcomes, but not on possible adverse events, therefore, we also judged it to be of unclear risk of reporting bias. </p> </section> <section id="CD006681-sec-0056"> <h4 class="title">Other potential sources of bias</h4> <p>We identified no other bias in the included studies and therefore, judged all included studies at low risk of other bias. </p> </section> </section> <section id="CD006681-sec-0057"> <h3 class="title" id="CD006681-sec-0057">Effects of interventions</h3> <p>See: <a href="./full#CD006681-tbl-0001"><b>Summary of findings for the main comparison</b> Low molecular weight heparin compared to no prophylaxis or placebo in prevention of venous thromboembolism in patients with lower‐limb immobilization</a> </p> <p><a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a> used a different study protocol, in which only patients with symptoms were examined using ultrasound. This can lead to an underestimation of the number of DVTs. Furthermore, primary asymptomatic DVT can still lead to late post‐thrombotic syndrome. Therefore, we considered asymptomatic DVT to be a relevant clinical outcome. However, due to the large number of included participants, we deemed this study valuable for this review. In order not to obscure the primary outcome, we only used the data from <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a> in the pulmonary embolism and symptomatic VTE analyses. </p> <section id="CD006681-sec-0058"> <h4 class="title">Morbidity</h4> <section id="CD006681-sec-0059"> <h5 class="title">Deep venous thrombosis (DVT)</h5> <p>Kujath and colleagues assessed 253 participants in their study, 126 of whom received a subcutaneous injection of Fraxiparin daily; 127 participants received no prophylaxis. Incidences of DVT were 16.5% (n = 21) in the control group and 4.8% (n = 6) in the LMWH group (odds ratio (OR) 0.25, 95% confidence interval (CI) 0.10 to 0.65; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>). Kock and colleagues assessed 163 participants in the control group (no treatment), and 176 participants in the LMWH once daily group. The incidence of DVT in the prophylaxis group was 0% versus 4.3% (n = 7) in the control group (OR 0.06, 95% CI 0.00 to 1.04; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>). In 2002, Jorgensen and colleagues published the results of their venographic‐controlled study, and diagnosed DVT in 10 out of 99 participants in the treatment group and in 18 out of 106 participants in the control group. This difference was not significant (OR 0.55, 95% CI 0.24 to 1.26; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>). In 2002, Lassen and colleagues found an incidence of 35 of 188 participants randomly assigned to receive placebo (18.6%) and in 17 of 183 participants (9%) in the LMWH group (OR 0.45, 95% CI 0.24 to 0.83; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). Lapidus and colleagues published two studies in 2007. The study on thromboprophylaxis after surgical treatment of Achilles tendon rupture revealed a high incidence of thromboembolic events: 37% (18/49) in the treatment group versus 40% (19/47) in the placebo group (OR 0.86, 95% CI 0.38 to 1.95; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>). The study on prolonged thromboprophylaxis during immobilization after ankle surgery also showed a high incidences without a significant difference between groups: 21% in the treatment group versus 31% in the placebo group (OR 0.57, 95% CI 0.31 to 1.04; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). In the first study published following the most recent update of this review in 2014, 719 participants received either dalteparin or nadroparin, 716 participants did not receive prophylaxis (<a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). Incidences of clinical relevant DVT were 1.0% (n = 7) in the treatment group and 1.3% (n = 9) in the control group (OR 0.77, 95% CI 0.29 to 2.09). The most recent study assessed 186 participants, 92 of whom received nadroparin, and 94 of whom received no prophylaxis. The treatment group showed a DVT incidence of 2.2% (n = 2), which was significantly lower than the DVT incidence of 11.7% (n = 11) in the control group (OR 0.17, 95% CI 0.04 to 0.78; <a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>). </p> <section id="CD006681-sec-0060"> <h6 class="title">Meta‐analysis</h6> <p>We conducted a meta‐analysis to establish whether there was evidence of a thromboprophylactic effect of LMWH, to estimate the size of this effect, and to investigate whether it was consistent across the included studies. We combined all participants, and subsequently assessed the effect for different groups of participants: surgically‐treated patients, patients with conservative treatment, patients with below‐knee casts, patients with cylinder or above‐knee casts, patients with fractures, patients with soft‐tissue injuries, PE, distal or proximal DVT, and finally, the number of patients with symptomatic VTE. </p> </section> <section id="CD006681-sec-0061"> <h6 class="title">All participants, regardless of type of plaster, whether operated or not</h6> <p>Seven studies, with a total of 1676 participants, had injuries of the lower limb immobilized by a plaster cast or brace (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). The control group (N = 834) received no prophylaxis or placebo; the prophylaxis group received LMWH once daily (N = 842). The incidence of thromboembolic events ranged from 4.3% to 40% in the control group (145/834), and from 0% to 37% (77/842) in the prophylaxis group (OR 0.45, 95% CI 0.33 to 0.61, P &lt; 0.001; <a href="./references#CD006681-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD006681-sec-0062"> <h6 class="title">Participants with below‐knee casts, whether operated or not</h6> <p>We were able to obtain data on specific analyses of DVT in below‐knee casts or braces from six studies (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a> and <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a> did not study the relationship between the type of cast and occurrence of thrombosis as part of their study designs. However, we could still add data from the group of participants with ruptured Achilles tendons from <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>. The incidences of DVT ranged from 0% to 37% in the LMWH groups, and from 3.6% to 40% in the control groups (OR 0.49, 95% CI 0.34 to 0.72; P &lt; 0.001; <a href="./references#CD006681-fig-0005" title="">Analysis 1.2</a>; N = 1080). </p> <p>Only <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a> provided data on participants with cylinder or above‐knee casts, with a DVT incidence of 0/24 (0%) in the LMWH group and 2/24 (8.3%) in the control group. </p> </section> <section id="CD006681-sec-0063"> <h6 class="title">Only participants with conservative treatment (i.e. non‐operated participants)</h6> <p>Five studies provided details of DVT in conservatively treated participants (i.e. non‐operated participants; <a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). When analyzed without consideration of type of cast or brace, the incidence ranged from 0% to 11.8% in the LMWH groups and from 4.3% to 17.3% in controls (OR 0.31, 95% CI 0.18 to 0.53, P &lt; 0.001; <a href="./references#CD006681-fig-0006" title="">Analysis 1.3</a>; N = 974). </p> </section> <section id="CD006681-sec-0064"> <h6 class="title">Only surgically‐treated participants</h6> <p>We obtained information about surgically‐treated participants from four studies (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). The incidence of DVT in surgically‐treated participants ranged from 7.2% to 37% in the LMWH group, and from 18.0% to 40% in the control group (OR 0.54, 95% CI 0.37 to 0.80, P = 0.002; <a href="./references#CD006681-fig-0007" title="">Analysis 1.4</a>; N = 699). </p> </section> <section id="CD006681-sec-0065"> <h6 class="title">Fractures or soft‐tissue injuries</h6> <p>Six studies provided information on participants with fractures (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). These groups contained both surgically and conservatively treated participants. We found results in favour of the LMWH groups (OR 0.48, 95% CI 0.33 to 0.70, P &lt; 0.001; <a href="./references#CD006681-fig-0008" title="">Analysis 1.5</a>; N = 1003). In participants with soft‐tissue injury, we again found results in favour of the LMWH groups (OR 0.39, 95% CI 0.22 to 0.68, P &lt; 0.001; <a href="./references#CD006681-fig-0009" title="">Analysis 1.6</a>; N = 658; <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). </p> </section> <section id="CD006681-sec-0066"> <h6 class="title">Distal or proximal deep vein thrombosis</h6> <p>Five studies provided information on the segment in which the thrombus was located (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>). The incidence of distal segment DVT, defined as below‐knee DVT, ranged from 0% to 34.7% in participants who received LMWH, and from 2.5% to 34.0% in the control groups (OR 0.61, 95% CI 0.42 to 0.89, P = 0.009; <a href="./references#CD006681-fig-0010" title="">Analysis 1.7</a>; N = 1208). Proximal DVT (above knee) was rare; there were eight events in a total of 614 participants who received LMWH (incidence ranged from 0% to 4.0%) versus 20/603 events in the controls (incidence ranged from 0.9% to 6.4%, OR 0.41, 95% CI 0.19 to 0.91, P = 0.03; <a href="./references#CD006681-fig-0011" title="">Analysis 1.8</a>; N = 1217). </p> </section> </section> <section id="CD006681-sec-0067"> <h5 class="title">Pulmonary embolism (PE)</h5> <p>In the studies under review, PE was a rare complication in immobilization of the lower extremity. <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a> reported that one participant in the treatment group and four participants in the control group showed clinical signs of PE; in two of them, both in the control group, PE was confirmed by a ventilation‐perfusion scan. <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a> reported that one participant in the group without prophylaxis showed clinical signs of a PE, but this diagnosis could not be proven by scintigraphic imaging. <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a> reported that four participants in the treatment group and five in the control group developed a PE, diagnosed with a spiral CT scan. In the PROTECT study, two participants in the control group developed a pulmonary embolism (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>). <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a> reported no cases of pulmonary embolism. Overall, no clear differences were found between the treatment and control groups (OR 0.50, 95% CI 0.17 to 1.47, P = 0.21; <a href="./references#CD006681-fig-0012" title="">Analysis 1.9</a>; N = 2517). </p> </section> <section id="CD006681-sec-0068"> <h5 class="title">Symptomatic venous thromboembolism (VTE) ‐ symptomatic deep venous thrombosis (DVT), pulmonary embolism (PE), or combination </h5> <p>All studies but one reported on participants with symptomatic VTE. <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a> did not report on participants with a symptomatic DVT, because it was not clinically possible to differentiate symptoms of a possible DVT from those of normal postoperative findings. <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a> reported on two events in the LMWH group and six events in the placebo group. <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a> mentioned two participants with PE and four with symptomatic DVT, all of them in the placebo group. <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a> reported on nine symptomatic participants, however, it was not clear whether they were in the treatment group or not. For that reason, this study was not included in the pooled analysis. <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a> did not report on symptomatic participants in their Lancet publication, but additional information from participants with thrombosis was found in an earlier publication. Four participants in the control group showed symptoms of DVT. <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a> did not find any symptomatic VTEs. <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a> reported six participants with symptomatic DVT, three with PE and one with both DVT and PE in the LMWH group, and eight with DVT, four with PE, and one participant with both, in the control group. <a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a> reported two participants with a PE in the control group. </p> <p>Symptomatic VTE was observed in 12 of 1469 (0.8%) participants receiving LMWH compared with 31 out of 1455 (2.1%) participants in the control group (OR 0.40, 95% CI 0.21 to 0.76; <a href="./references#CD006681-fig-0013" title="">Analysis 1.10</a>; six RCTs; N = 2924). </p> </section> </section> <section id="CD006681-sec-0069"> <h4 class="title">Mortality (Pulmonary embolism‐ (PE)‐related and other causes)</h4> <p><a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a> reported one death in the no treatment group during their three‐month follow‐up after treatment; they reported that the death was assessed as possibly due to pulmonary embolism. However, a conclusive diagnosis could not be made because no autopsy was performed; the participant was over 90 years old and suffered from heart failure. The remaining seven studies reported no deaths due to PE (<a href="./references#CD006681-fig-0014" title="">Analysis 1.11</a>; N = 3111), or other causes (<a href="./references#CD006681-fig-0015" title="">Analysis 1.12</a>; N = 3111). </p> </section> <section id="CD006681-sec-0070"> <h4 class="title">Adverse outcomes of treatment</h4> <p>Major side effects, such as hematoma, acute major bleeding, allergic reaction, and thrombocytopenia were rare. </p> <p><a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a> reported 14 participants in the LMWH group and 12 in the placebo group had a bleeding event. <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a> also reported major bleeding occurred in two participants in the LMWH group (retroperitoneal bleeding in one and permanent discontinuation of LMWH due to minor bleeding in another) and one in the placebo group (permanent discontinuation of study medication due to minor bleeding). <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a> reported no cases of heparin induced thrombocytopenia (HIT). <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a> reported on five participants with minor complications (four small local hematomas, one facial eczema). <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a> reported no cases of HIT, hematomas, or severe bleeding. <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a> did not observe any side effects. Lapidus and colleagues did not report any cases of major bleeding (<a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a> reported one participant had a nosebleed after two days of dalteparin treatment. In <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>, two participants (one in each group) discontinued treatment due to minor bleeding. <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a> reported no major bleeds, one clinically relevant non‐major bleed in the LMWH group, 55 minor bleeds in the treatment group, and 49 minor bleeds in the control group. <a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a> reported no major complications. Twenty‐two participants in the treatment group reported minor bleeding, hematuria, or dark stool (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>). </p> <p>Combining all reported adverse events into a random‐effects model meta‐analysis showed an OR of 2.01, 95% CI 0.83 to 4.86, I² = 57%, 3178 participants; 8 studies; <a href="./references#CD006681-fig-0016" title="">Analysis 1.13</a>). </p> <p>See also <a href="./full#CD006681-tbl-0001">summary of findings Table for the main comparison</a> </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006681-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006681-sec-0071"></div> <section id="CD006681-sec-0072"> <h3 class="title" id="CD006681-sec-0072">Summary of main results</h3> <p>We included eight studies in this updated review, with a total of 3680 participants. From these studies, we found that the incidence of deep venous thrombosis (DVT), diagnosed by compression ultrasound, venography, or both, in participants with a leg injury who were immobilized in a plaster cast or brace for at least one week and received no thromboprophylaxis (or placebo) was 4.3% to 40%. This was significantly higher than for participants who received daily subcutaneous injections of low molecular weight heparin (LMWH) during the entire period of immobilization (0% to 37%). </p> <p>Comparable results were seen in the following groups of participants: patients with a below‐knee cast, surgically treated patients, conservatively treated patients (not surgically treated), patients with fractures, patients with soft‐tissue injuries, and patients with proximal or distal DVT. The odds ratios (OR) between the individual participant groups were similar, with an overlap of the confidence intervals (CI). Therefore, it was not possible to indicate a participant or patient group where prophylaxis was not indicated. No clear differences were found for PE between LMWH and the control groups. The studies found less symptomatic venous thromboembolism (VTE) in the LMWH groups compared with the control groups. One death (in the control group) was reported in the included studies. Major adverse events were rare; the main adverse events reported were cases of minor bleeding. </p> </section> <section id="CD006681-sec-0073"> <h3 class="title" id="CD006681-sec-0073">Overall completeness and applicability of evidence</h3> <p>The studies included in this review all assessed participants with lower‐limb immobilization. Some studies only included conservatively treated participants, whereas, others also included surgically treated participants. Studies included participants with both fractures and soft‐tissue injuries. These differences in inclusion criteria may have led to a lower external validity. </p> <p>In addition to using Cochrane's 'Risk of bias' tool to assess methodological quality, we also assessed the validity and quality of the included randomized controlled trials using the scoring scheme provided on the website of Cochrane Netherlands (<a href="http://www.cochrane.nl" target="_blank">www.cochrane.nl</a>). The overall quality of the eight included studies according to this scoring system, was rated 'good', although some remarks should be added. </p> <p>The true thromboembolic rate in unprotected patients remains unknown, as high‐risk patients were excluded from participation in all eight studies, underestimating the incidence of thromboembolism in unprotected patients and the potentially beneficial effect of LMWHs. Although there is consensus among surgeons that thromboprophylaxis should be initiated in patients with a moderate to high risk for thromboembolism, there is no uniform definition of this patient group, leading to practice variation. Several attempts have been made to stratify the risk for VTE of immobilized patients (<a href="./references#CD006681-bbs2-0066" title="GearhartMM , LuchetteFA , ProctorMC , LutomskiDM , WitskenC , JamesL , et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery2000;128(4):631‐40. ">Gearhart 2000</a>; <a href="./references#CD006681-bbs2-0055" title="ZagrodnickJ , KaufnerHK . Ambulatory thromboembolism prevention in traumatology using self‐injection of heparin. Unfallchirurg1990;93(7):331‐3. [Article in German] ">Zagrodnick 1990</a>). <a href="./references#CD006681-bbs2-0036" title="KnudsonMM , IkossiDG , KhawL , MorabitoD , SpeetzenL . Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Annals of Surgery2004;240(3):490–6, discussion 496‐8. ">Knudson 2004</a> developed a scheme, based on analysis of 1602 episodes of VTE using the National Trauma Data Bank, to identify trauma patients with a high risk of thrombosis. Lower‐limb fracture and age over 40 years were among the factors used for selection. However, this study also stated that with this scheme, 90% of patients with VTE would be identified, and 10% would be missed. By contrast, in another study, patients under 40 years of age, with soft‐tissue injuries also developed DVT (<a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>). Up to now, no stratification method has proven its superiority or has gained general acceptance. In most studies in this review, investigators did not include patients with a high risk of DVT. So even in patients with a low to average risk of DVT, LMWH still provided significant protection. </p> <p>In five studies, the included participants had a wide variety of trauma, ranging from fractures to soft‐tissue injuries, and tendon ruptures (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). Since the risk of DVT is found to be related to the presence and type of fracture, the extent of soft‐tissue injury, and type and duration of surgery, heterogeneity might have been introduced. However, randomization should have minimized this effect. Three studies focused on participants with a specific trauma (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). We also observed a high drop‐out rate. </p> <p>Five studies used ultrasound (<a href="./references#CD006681-bbs2-0001" title="BruntinkMM , GroutarsYM , SchipperIB , BreederveldRS , TuinebreijerWE , DerksenRJ , PROTECT Study Group. Nadroparin or fondaparinux versus no thromboprophylaxis in patients immobilised in a below‐knee plaster cast (PROTECT): a randomised controlled trial. Injury2017;376:936‐40. [PUBMED: 28279428] DerksenRJ , GroutarsYME , Van deBrandJG . Trial setup and preliminary results of PROTECT: prophylaxis of thromboembolic complications trial. European Journal of Trauma and Emergency Surgery2011;37(Suppl 1):S141. NTR1733 . Prevention of thrombosis in patients who are treated with a plaster cast for a fracture of the ankle or foot. www.trialregister.nl/trialreg/admin/rctview.asp?TC=1733 (Date registered 23 March 2009). ">Bruntink 2017</a>; <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>; <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a>, <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>; <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>), and three used venography (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>), to diagnose DVT. The latter is considered the 'gold standard', but is rarely used in routine practice as the first line of investigation for DVT. Duplex ultrasonography and compression ultrasonography have a lower sensitivity and specificity compared to venography, especially for diagnosing calf vein thrombosis (<a href="./references#CD006681-bbs2-0062" title="CBO (Centraal Begeleidingsorgaan voor de intercollegialetoetsing) . Concept directive diagnostics, prevention and treatment of venous thromboembolism and secondary prevention of arterial thrombosis [Conceptrichtlijn diagnostiek, preventie en behandeling van veneuze tromboembolie en secundaire preventie arteriële trombose]. Quality Institute for Health Care (Kwaliteitsinstituut voor de Gezondheidszorg), the Netherlands (http://www.cvgk.nl/legacy/bestanden/CBO‐richtlijn‐Stolling‐2009.pdf)2008. ">CBO 2008</a>; <a href="./references#CD006681-bbs2-0075" title="LensingAWA , PrandoniP , BrandjesD , HuismanPM , VigoM , TomasellaG , et al. Detection of deep‐vein thrombosis by real‐time B‐mode ultrasonography. New England Journal of Medicine1989;320(6):342‐5. ">Lensing 1989</a>). This might be the reason for the differences in the results between <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a> and the studies that used venography (<a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a>; <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>; <a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a>), since there were no other major differences reported in participant characteristics or intervention. However, it does not explain the differences between the results of <a href="./references#CD006681-bbs2-0003" title="KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskiG . Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Vasa Supplementum1992;35:105‐6. KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Ambulant thrombosis prophylaxis with low‐molecular heparin in plaster immobilisation of the lower extremities. Hefte zur der Unfallchirurg1993;232:245‐6. [Article in German] KockHJ , Schmit‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG , et al. Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity. Der Chirurg1993;64(6):483‐91. KockHJ , Schmit‐NeuerburgKP , HankeJ , RudofskyG , HircheH . Thromboprophylaxis with low‐molecular‐weight heparin in outpatients with plaster‐cast immobilisation of the leg. Lancet 1995 Aug 19;346(8973):459‐61. KockHJ , Schmit‐NeuerburgKP , HankeJ , TerwortA , RudofskyG , HircheH . Patient compliance during low molecular weight heparin thromboprophylaxis in outpatients with plaster cast immobilisation of the leg. Unfallchirurgie1994;20(6):319‐28. KockHJ , Schmitt‐NeuerburgKP , HankeJ , HakmannA , AlthoffM , RudofskyG . Prophylaxis of venous thromboembolism with low molecular weight heparin in surgical outpatients with immobilization of the lower limb by plaster cast. Haemostaseologie1993;13 (suppl):S36‐S39. ">Kock 1995</a>, <a href="./references#CD006681-bbs2-0004" title="HabscheidW , SpannagelU , KujathP , SchindlerG . Prevention of thrombosis with low molecular weight heparin in ambulatory patients with injury of the lower extremity: an ultrasound study. Vasa Supplementum1991;33:222‐3. KujathP , EckmannC . Thromboembolism prophylaxis in ambulatory surgery. Aktuelle Chirurgie1995;30(6):372‐5. KujathP , SpannagelU , HabscheidW . Incidence and prophylaxis of deep venous thrombosis in outpatients with injury of the lower limb. Haemostasis1993;23(suppl 1):20‐6. KujathP , SpannagelU , HabscheidW , SchindlerG , WeckbachA . Thrombosis prevention in outpatients with lower limb injuries. Deutsche Medizinische Wochenschrift1992;117(1):6‐10. ">Kujath 1993</a> and <a href="./references#CD006681-bbs2-0005" title="LapidusL , RosforsS , PonzerS , LevanderC , ElvinA , ElvinG , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture ‐ a randomized, placebo‐controlled study. Journal of Bone and Joint Surgery ‐ British Volume2009;91‐B(Suppl 1):165. LapidusLJ , RosforsS , PonzerS , LevanderC , ElvinA , LaerfarsG , et al. Prolonged thromboprophylaxis with Dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo‐controlled study. Journal of Orthopaedic Trauma2007;21(1):52‐7. ">Lapidus 2007a</a>. By only examining participants reporting symptoms, <a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a> only reported clinically‐relevant DVTs, therefore underestimating the number of DVTs in the study population. Due to this difference in study protocol, we only used the results of this study in the analyses for pulmonary embolism (<a href="./references#CD006681-fig-0012" title="">Analysis 1.9</a>) and symptomatic VTE (<a href="./references#CD006681-fig-0013" title="">Analysis 1.10</a>). </p> <p><a href="./references#CD006681-bbs2-0007" title="AhmadS , BacherHP , LassenMR , HoppensteadtDA , LeitzH , MisselwitzF , et al. Investigations of the immunoglobulin subtype transformation of anti‐heparin‐platelet factor 4 antibodies during treatment with a low‐molecular‐weight heparin (clivarin) in orthopaedic patients. Archives of Pathology and Laboratory Medicine2003;127(5):584‐8. LassenMR , BorrisLC , NakovRL . Use of the low‐molecular‐weight heparin reviparin to prevent deep‐vein thrombosis after leg injury requiring immobilization. New England Journal of Medicine2002;347(10):726‐30. ">Lassen 2002</a> included participants who received up to four days of LMWH (32% of participants). Another study treated all participants with LMWH for one week prior to randomization (<a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a>). This might equalize the effects in the two groups and lead to an underestimation of the treatment effect. Therefore, <a href="./references#CD006681-bbs2-0006" title="LapidusLJ , PonzerS , ElvinA , LevanderC , LaerfarsG , RosforsS , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized, placebo‐controlled, double‐blind study. Acta Orthopaedica2007;78(4):528‐35. ">Lapidus 2007b</a> only focused on the duration of treatment, and not on the indication of treatment itself. </p> <p>The dose of 3500 anti‐Xa IU of tinzaparin that <a href="./references#CD006681-bbs2-0002" title="JorgensenPS , Warming , HansenK , PaltredC , BergH , JensenR . Low molecular weight heparin (Innohep) thromboprophylaxis in outpatients with plaster casts. A phlebografic controlled study. Danish Orthopaedic Society Autumn Meeting. Copenhagen, Denmark, October 26‐27 2000. JorgensenPS , WarmingT , HansenK , PaltvedC , BergHV , JensenR , et al. Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast; a venography controlled study. Thrombosis Research2002;105(6):477‐80. ">Jorgensen 2002</a> used might have been too low, since another study showed equal antithrombotic effect using 4500 anti‐Xa IU of tinzaparin compared with 40 mg of enoxaparin, which is the standard dose in orthopedic surgery (<a href="./references#CD006681-bbs2-0020" title="ErikssonBI , BauerKA , LassenMR , TurpieAG . Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip‐fracture surgery. Steering Committee of the Pentasaccharide in Hip‐Fracture Surgery Study. New England Journal of Medicine2001;345(18):1298‐304. ">Eriksson 2001</a>). This possibly creates an underestimation of the effect of prophylaxis. </p> </section> <section id="CD006681-sec-0074"> <h3 class="title" id="CD006681-sec-0074">Quality of the evidence</h3> <p>The quality of evidence according GRADE varied by outcome and ranged from low to moderate with reasons for downgrading being risk of bias due to attrition and performance bias (DVT), imprecision and risk of bias due to attrition and performance bias (PE, symptomatic VTE and adverse outcomes) and low number of events and imprecision (mortality due to other causes). </p> <p>See also <a href="./full#CD006681-tbl-0001">summary of findings Table for the main comparison</a> </p> </section> <section id="CD006681-sec-0075"> <h3 class="title" id="CD006681-sec-0075">Potential biases in the review process</h3> <p>Two review authors independently carried out study selection, data extraction, and study quality assessment in order to reduce bias and subjectivity. We are confident that all potential studies are included in this review. However, the possibility remains that relevant data exist which have not been published or were not found in the search. </p> <p>The total number of included studies in this review was eight. Since ten studies are required to perform a funnel plot analysis, reliable funnel plot analysis could not be performed. </p> <p>By only examining patient reporting symptoms Van Adrichem 2016 only reported clinical relevant DVTs, therefore underestimating the number of DVTs in the study population. Due to this difference in study protocol the results of this study were only used in the analyses for 'pulmonary embolism' (<a href="./references#CD006681-fig-0012" title="">Analysis 1.9</a>) and 'symptomatic VTE' (<a href="./references#CD006681-fig-0013" title="">Analysis 1.10</a>). </p> </section> <section id="CD006681-sec-0076"> <h3 class="title" id="CD006681-sec-0076">Agreements and disagreements with other studies or reviews</h3> <p>As early as 1944, the first study on deep venous thrombosis (DVT) following leg injuries was published, reporting incidence rates of 7% to 18% (<a href="./references#CD006681-bbs2-0015" title="BauerG . Thrombosis following leg injuries. Acta Chirurgica Scandinavica1944;90:229‐49. ">Bauer 1944</a>). Nonfatal and fatal pulmonary embolism (PE) complicate DVT of the lower extremities. Fatal PE used to be a common cause of death in hospitals, because of the often clinically occult nature of DVT. </p> <p>The discussion on the use of LMWH in immobilization of the lower limb focuses on the following issues: the reduction of symptomatic VTE, the reduction of asymptomatic DVT, the relevance of asymptomatic DVT, and the incidence of complications. With meta‐analyses, we were able to show that the use of LMWH in immobilization of the lower limb following leg injury results in a reduction of symptomatic VTE and of (asymptomatic) DVT. </p> <p>Over 80% of DVTs diagnosed were located distally. Calf vein thrombosis propagates and becomes proximal in between 0% and 25% of patients, accounting for a mean of 10%. Up to 10% of proximal DVTs embolize massively, and are potentially fatal (<a href="./references#CD006681-bbs2-0057" title="Anonymous . Consensus conference: prevention of venous thrombosis and pulmonary embolism. JAMA1986;256(6):744‐9. ">Anonymous 1986</a>; <a href="./references#CD006681-bbs2-0080" title="SchellongSM . Distal DVT: worth diagnosing? Yes. Journal of Thrombosis and Haemostasis2007;5(Suppl.1):51‐4. ">Schellong 2007</a>). Opinions differ about the risk of post‐thrombotic syndrome (PTS) after distal DVT. It is stated that the risk is considerably lower than in proximal DVT. Results are inconsistent for the relationship between the location of the initial thrombus and the subsequent development of PTS. Some prospective studies reported rates of PTS after distal DVT that were as high as 20% to 80% (<a href="./references#CD006681-bbs2-0077" title="McLaffertyRB , MonetaGL , PassmanMA , BrantBB , TaylorLMJr , PorterJM . Late clinical and hemodynamic sequelae of isolated calf vein thrombosis. Journal of Vascular Surgery1998;27(1):50–6. ">McLafferty 1998</a>; <a href="./references#CD006681-bbs2-0081" title="SchulmanS , GranqvistS , Juhlin‐DannfeltA , LocknerD . Long‐term sequelae of calf vein thrombosis treated with heparin or low‐dose streptokinase. Acta Medica Scandinavica1986;219(4):349–57. ">Schulman 1986</a>). Hence, distal DVT appears to be associated with a substantial risk of subsequent PTS. Further research is indicated to elicit the exact role of distal DVT in the development of PTS (<a href="./references#CD006681-bbs2-0072" title="KahnSR . The post‐thrombotic syndrome: progress and pitfalls. British Journal of Haematology2006;134(4):357–65. ">Kahn 2006</a>). </p> <p>The incidence of complications in the review seemed to be low compared with data in the literature. Major bleeding was reported in 0.27% (two out of 1469 participants) and minor bleeding in up to 7.8% of participants (<a href="./references#CD006681-bbs2-0008" title="NCT01542762 . Pot‐Cast: thrombosis prophylaxis during plaster cast lower leg immobilisation. clinicaltrials.gov/ct2/show/NCT01542762?term=nct01542762&amp;rank=1 (Date first received 27 February 2012). VanAdrichemRA , NemethB , AlgraA , leCessieS , RosendaalFR , SchipperIB , et al. Thromboprophylaxis after knee arthroscopy and lower‐leg casting. New England Journal of Medicine2017;376(6):515‐25. [PUBMED: 27959702] ">Van Adrichem 2017</a>). In contrast, <a href="./references#CD006681-bbs2-0047" title="ReilmannH , WeinbergAM , ForsterEE , HappeB . Prevention of thrombosis in ambulatory patients. Orthopade1993;22(2):117‐20. [Article in German] ">Reilmann 1993</a> reported up to 14% of participants with hematomas due to injections. Another study even described it up to 28%, although some of the participants were not treated with LMWH, but with unfractionated heparin (<a href="./references#CD006681-bbs2-0055" title="ZagrodnickJ , KaufnerHK . Ambulatory thromboembolism prevention in traumatology using self‐injection of heparin. Unfallchirurg1990;93(7):331‐3. [Article in German] ">Zagrodnick 1990</a>). In our seven included studies, no cases of heparin‐induced thrombocytopenia were described, which is in concordance with the observation that this condition is seldom seen in combination with LMWH (<a href="./references#CD006681-bbs2-0061" title="BloemenA , TestrooteMJ , Janssen‐HeijnenML , JanzingHM . Incidence and diagnosis of heparin‐induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low‐molecular‐weight heparin: a literature review. Injury2012;43:548‐52. ">Bloemen 2012</a>). </p> <p>The eight studies used different types of LMWH. The total number of participants was insufficient to evaluate which type of LMWH to choose. Evidence published so far indicates that any differences between LMWH preparations, if they exist, must be extremely small (<a href="./references#CD006681-bbs2-0067" title="GeertsWH , PineoGF , HeitJA , BergqvistD , LassenMR , ColwellCW , et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004;126 (3 Suppl):338S‐400S. ">Geerts 2004</a>). It is unlikely that a properly sized and designed study comparing the various LMWHs will ever take place. Sample size calculations quickly reach over 10,000 if one considers appropriate definitions of 'non‐inferiority' when comparing the various antithrombotic regimens (<a href="./references#CD006681-bbs2-0082" title="VaitkusPT . Thromboprophylaxis in immobilized medical patients. European Journal of Medical Research2004;9(3):131‐4. ">Vaitkus 2004</a>). </p> <p>Venography is considered the most accurate method of diagnosing DVT but is now rarely used in clinical practice (<a href="./references#CD006681-bbs2-0009" title="AbelsethG , BuckleyRE , PineoGE , HullR , RoseMS . Incidence of deep‐vein thrombosis in patients with fractures of the lower extremity distal to the hip. Journal of Orthopaedic Trauma1996;10(4):230‐5. ">Abelseth 1996</a>; <a href="./references#CD006681-bbs2-0060" title="BergqvistD , LoweG . Venous thromboembolism in patients undergoing laparoscopic and arthroscopic surgery and in leg casts. Archives of Internal Medicine2002;162(19):2173‐6. ">Bergqvist 2002</a>). It is an invasive procedure, and there is a reported incidence of serious adverse reactions to the contrast media in the range of 0.4% to 2% (<a href="./references#CD006681-bbs2-0076" title="LensingAW , PrandoniP , BullerHR , CasaraD , CogoA , tenCateJW . Lower extremity venography with iohexol: results and complications. Radiology1990;177(2):503‐5. ">Lensing 1990</a>). Duplex ultrasound is the most common non‐invasive test used to diagnose venous thrombosis of the extremities. Compared with venography, ultrasound has been shown to be reliable in the diagnosis of proximal symptomatic DVT, with a sensitivity and specificity of over 90%. However, for distal thrombosis, a sensitivity of 73% can be reached when combining compression ultrasound with color‐doppler ultrasound (<a href="./references#CD006681-bbs2-0062" title="CBO (Centraal Begeleidingsorgaan voor de intercollegialetoetsing) . Concept directive diagnostics, prevention and treatment of venous thromboembolism and secondary prevention of arterial thrombosis [Conceptrichtlijn diagnostiek, preventie en behandeling van veneuze tromboembolie en secundaire preventie arteriële trombose]. Quality Institute for Health Care (Kwaliteitsinstituut voor de Gezondheidszorg), the Netherlands (http://www.cvgk.nl/legacy/bestanden/CBO‐richtlijn‐Stolling‐2009.pdf)2008. ">CBO 2008</a>). Considering the properties of the imaging methods used to diagnose PE, a recent systematic review showed a sensitivity of 86% for the ventilation‐perfusion scintigraphy and a specificity of 46% compared with pulmonary angiography. For the CT scan, the percentages were 85% sensitivity and 94% specificity (<a href="./references#CD006681-bbs2-0069" title="HayashinoY , GotoM , NoguchiY , FukuiT . Ventilaton‐perfusion scanning and helical CT in suspected pulmonary embolism: Meta‐analysis of diagnostic performance. Radiology2005;234(3):740‐8. ">Hayashino 2005</a>). Consequently, the number of instances of missed DVT and PE seems to be acceptable when including studies with different diagnostic procedures, and should not influence our conclusions to a major extent. However, an underestimation of the incidence of VTE can occur when using ultrasound, CT‐scan, or ventilation‐perfusion scanning. </p> <p>Increased incidence of DVT in an untreated population calls for measures, and thromboprophylaxis seems necessary if immobilization in a cast or brace is needed. Post‐traumatic DVT can lead to PE or long‐term damage in the form of PTS (<a href="./references#CD006681-bbs2-0073" title="KakkarVV . Prevention of venous thromboembolism. In: BloomAL , ForbesCD , ThomasDP , TuddenhamEGD editor(s). Haemostasis and thrombosis. 3rd Edition. Edinburgh: Churchill Livingstone, 1994:1361‐79. ">Kakkar 1994</a>). Low molecular weight heparin has been shown to be effective in reducing the incidence of VTE. The possible complications of major bleeding events (2/750 participants or 0.3%), and heparin‐induced thrombopenia (none in this review) have been shown to be extremely rare, and do not outweigh the beneficial effect of the reduction of thromboses. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006681-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram" data-id="CD006681-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias domain, presented as percentages across all included studies" data-id="CD006681-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias domain, presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias domain for each included study" data-id="CD006681-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias domain for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 1 Deep venous thrombosis: regardless of type of plaster, whether operated or not." data-id="CD006681-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 1 Deep venous thrombosis: regardless of type of plaster, whether operated or not. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 2 Deep venous thrombosis: in below‐knee cast, whether operated or not." data-id="CD006681-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 2 Deep venous thrombosis: in below‐knee cast, whether operated or not. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 3 Deep venous thrombosis: conservative treatment (i.e. non‐operated patients)." data-id="CD006681-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 3 Deep venous thrombosis: conservative treatment (i.e. non‐operated patients). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 4 Deep venous thrombosis: operated patients." data-id="CD006681-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 4 Deep venous thrombosis: operated patients. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 5 Deep venous thrombosis: fractures." data-id="CD006681-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 5 Deep venous thrombosis: fractures. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 6 Deep venous thrombosis: soft‐tissue injuries." data-id="CD006681-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 6 Deep venous thrombosis: soft‐tissue injuries. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 7 Deep venous thrombosis: distal segment." data-id="CD006681-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 7 Deep venous thrombosis: distal segment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 8 Deep venous thrombosis: proximal segment." data-id="CD006681-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 8 Deep venous thrombosis: proximal segment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 9 Pulmonary embolism." data-id="CD006681-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 9 Pulmonary embolism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 10 Symptomatic venous thromboembolism." data-id="CD006681-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 10 Symptomatic venous thromboembolism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 11 Mortality due to pulmonary embolism." data-id="CD006681-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 11 Mortality due to pulmonary embolism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 12 Mortality due to other causes." data-id="CD006681-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 12 Mortality due to other causes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006681-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/urn:x-wiley:14651858:media:CD006681:CD006681-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_t/tCD006681-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 13 Adverse outcomes." data-id="CD006681-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Low molecular weight heparin versus no prophylaxis or placebo, Outcome 13 Adverse outcomes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/media/CDSR/CD006681/image_n/nCD006681-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006681-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Low molecular weight heparin compared to no prophylaxis or placebo in prevention of venous thromboembolism in patients with lower‐limb immobilization</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="7" rowspan="1" valign="top"> <p><b> Low molecular weight heparin compared to no prophylaxis or placebo in prevention of venous thromboembolism in patients with lower‐limb immobilization</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> prevention of venous thromboembolism in patients with lower‐limb immobilization<br/> <b>Setting:</b> ambulatory setting<br/> <b>Intervention:</b> low molecular weight heparin<br/> <b>Comparison:</b> no prophylaxis or placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with no prophylaxis or placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with low molecular weight heparin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Deep venous thrombosis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.45<br/> (0.33 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1676<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/> (65 to 114) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pulmonary embolism</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.50<br/> (0.17 to 1.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2517<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 10) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Symptomatic venous thromboembolism</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.40<br/> (0.21 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2924<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (5 to 16) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to pulmonary embolism</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3111<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No mortality due to pulmonary embolism was reported</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to other causes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 0.33</p> <p>(0.01 to 8.15)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3111<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One death (in no prophylaxis/placebo group) was reported in the included studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> <p>(0 to 5)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>OR 2.01<br/> (0.83 to 4.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3178<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/> (34 to 170) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*We calculated the assumed risk of the no prophylaxis or placebo group from the average risk in the no prophylaxis or placebo groups (i.e. the number of participants with events divided by total number of participants of the no prophylaxis or placebo group included in the meta‐analysis). The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>OR:</b> odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded by one level as 3 out of 7 studies showed considerable risk of bias<br/> <sup>2</sup> Downgraded by two levels as 2 out of 5 studies showed considerable risk of bias, and imprecision of pooled results<br/> <sup>3</sup> Downgraded by two levels as 3 out of 6 studies showed considerable risk of bias, and imprecision of pooled results<br/> <sup>4</sup> Downgraded by two levels due to the low number of events, and imprecision of pooled results<br/> <sup>5</sup> Downgraded by two levels as 4 out of 8 studies showed considerable risk of bias, and imprecision of pooled results </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Low molecular weight heparin compared to no prophylaxis or placebo in prevention of venous thromboembolism in patients with lower‐limb immobilization</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/full#CD006681-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006681-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Low molecular weight heparin versus no prophylaxis or placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Deep venous thrombosis: regardless of type of plaster, whether operated or not <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.33, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Deep venous thrombosis: in below‐knee cast, whether operated or not <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1080</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.34, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Deep venous thrombosis: conservative treatment (i.e. non‐operated patients) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>974</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.18, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Deep venous thrombosis: operated patients <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>699</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.37, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Deep venous thrombosis: fractures <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.33, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Deep venous thrombosis: soft‐tissue injuries <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>658</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.22, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Deep venous thrombosis: distal segment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.42, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Deep venous thrombosis: proximal segment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.19, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Pulmonary embolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.17, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Symptomatic venous thromboembolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2924</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.21, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mortality due to pulmonary embolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mortality due to other causes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Adverse outcomes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.01 [0.83, 4.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Low molecular weight heparin versus no prophylaxis or placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006681.pub4/references#CD006681-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006681.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006681-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006681-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD006681-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006681-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006681\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006681\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006681\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006681\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006681\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6iOnQIUh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006681.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006681.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006681.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006681.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006681.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718310699"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006681.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718310703"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006681.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcd3bcb93935f',t:'MTc0MDcxODMxMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 